Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT07267130
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. 33
Early research (Phase 1)Study completedNCT06160440
What this trial is testing

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Who this might be right for
Diopathic Pulmonary FibrosisPulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 55
Early research (Phase 1)Study completedNCT01116089
What this trial is testing

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 25
Early research (Phase 1)Study completedNCT03189589
What this trial is testing

Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT01300533
What this trial is testing

BIND-014 Given to Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerCancerSolid Tumors
BIND Therapeutics 58
Large-scale testing (Phase 3)Study completedNCT01072149
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54
Early research (Phase 1)Study completedNCT06589921
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 24
Early research (Phase 1)Looking for participantsNCT07274852
What this trial is testing

Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Lung CancerBreast CancerHead and Neck Squamous Cell Carcinoma+1 more
Sichuan Baili Pharmaceutical Co., Ltd. 22
Early research (Phase 1)Study completedNCT02359357
What this trial is testing

FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 130
Testing effectiveness (Phase 2)UnknownNCT05552781
What this trial is testing

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
RedCloud Bio 76
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Early research (Phase 1)Study completedNCT02666287
What this trial is testing

GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 48
Early research (Phase 1)Study completedNCT01577680
What this trial is testing

Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT02196714
What this trial is testing

PK Study of PT003 and PT001 in Japanese Healthy Subjects

Who this might be right for
COPD
Pearl Therapeutics, Inc. 24
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Early research (Phase 1)Ended earlyNCT04991194
What this trial is testing

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 61
Testing effectiveness (Phase 2)Looking for participantsNCT06602557
What this trial is testing

" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "

Who this might be right for
Pneumonia, BacterialExtracorporeal Membrane Oxygenation
Assistance Publique - Hôpitaux de Paris 26
Not applicableStudy completedNCT01983839
What this trial is testing

PK Analysis of Moxifloxacin in the Treatment of CAP

Who this might be right for
Pneumonia
University of Aarhus 18
Early research (Phase 1)Ended earlyNCT02448251
What this trial is testing

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
ACEA Therapeutics, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT04780321
What this trial is testing

JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects

Who this might be right for
COVID-19
Shanghai Junshi Bioscience Co., Ltd. 62
Next Page